Bruce Jackson
Stock Analyst at Benchmark Co.
(0.09)
# 4,703
Out of 5,010 analysts
304
Total ratings
37.2%
Success rate
-8.8%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNCY Unicycive Therapeutics | Reiterated: Buy | $13 → $15 | $4.64 | +223.28% | 12 | Aug 20, 2026 | |
| PODD Insulet | Reiterated: Buy | $250 → $185 | $133.11 | +38.98% | 2 | Aug 6, 2026 | |
| DXCM DexCom | Reiterated: Buy | $77 → $82 | $86.68 | -5.40% | 2 | Jul 31, 2026 | |
| NEO NeoGenomics | Reiterated: Buy | $11 → $16 | $19.29 | -17.06% | 24 | Jul 24, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $20 | $20.49 | -2.39% | 2 | Jun 3, 2026 | |
| HUMA Humacyte | Reiterated: Buy | $1 → $2 | $0.5472 | +265.50% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Reiterated: Buy | $3 | $1.13 | +165.49% | 20 | May 19, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $16.42 | - | 1 | May 11, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $145 → $120 | $100.98 | +18.84% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Reiterated: Buy | $14 → $10 | $6.92 | +44.51% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $20 | $2.47 | +709.72% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $6 | $7.92 | -24.24% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $187 → $217 | $165.93 | +30.78% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $4.06 | +663.55% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.25 → $1 | $0.41 | +143.90% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.65 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $140 | $0.4781 | n/a | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.2529 | n/a | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $11.24 | n/a | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.01 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.7383 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.35 → $2 | $1.89 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $24 | $2.86 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.527 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $0.4 | $0.000001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $960 → $240 | $0.0001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $20.87 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $5 | $3.18 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.925 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $4 | $4.43 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.6675 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.11 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.28 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.2918 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $43.36 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.69 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.971 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $16.27 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $89.50 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $44.11 | n/a | 2 | Mar 2, 2012 |
Unicycive Therapeutics
Aug 20, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $4.64
Upside: +223.28%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $250 → $185
Current: $133.11
Upside: +38.98%
DexCom
Jul 31, 2026
Reiterated: Buy
Price Target: $77 → $82
Current: $86.68
Upside: -5.40%
NeoGenomics
Jul 24, 2026
Reiterated: Buy
Price Target: $11 → $16
Current: $19.29
Upside: -17.06%
MiniMed Group
Jun 3, 2026
Reiterated: Buy
Price Target: $20
Current: $20.49
Upside: -2.39%
Humacyte
Jun 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.5472
Upside: +265.50%
Biofrontera
May 19, 2026
Reiterated: Buy
Price Target: $3
Current: $1.13
Upside: +165.49%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $16.42
Upside: -
Abbott Laboratories
Apr 17, 2026
Reiterated: Buy
Price Target: $145 → $120
Current: $100.98
Upside: +18.84%
CapsoVision
Mar 27, 2026
Reiterated: Buy
Price Target: $14 → $10
Current: $6.92
Upside: +44.51%
Mar 20, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $2.47
Upside: +709.72%
Mar 16, 2026
Reiterated: Buy
Price Target: $20 → $6
Current: $7.92
Upside: -24.24%
Mar 3, 2026
Reiterated: Buy
Price Target: $187 → $217
Current: $165.93
Upside: +30.78%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $4.06
Upside: +663.55%
Nov 20, 2025
Reiterated: Buy
Price Target: $1.25 → $1
Current: $0.41
Upside: +143.90%
Nov 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.65
Upside: -
Sep 15, 2025
Reiterated: Buy
Price Target: $280 → $140
Current: $0.4781
Upside: n/a
Sep 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.2529
Upside: n/a
Apr 24, 2025
Reiterated: Buy
Price Target: $30
Current: $11.24
Upside: n/a
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $2.01
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.7383
Upside: n/a
Jun 6, 2024
Reiterated: Buy
Price Target: $1.35 → $2
Current: $1.89
Upside: n/a
Apr 15, 2024
Reiterated: Buy
Price Target: $40 → $24
Current: $2.86
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.527
Upside: n/a
Mar 22, 2024
Reiterated: Buy
Price Target: $4 → $0.4
Current: $0.000001
Upside: n/a
Sep 21, 2023
Reiterated: Buy
Price Target: $960 → $240
Current: $0.0001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $20.87
Upside: n/a
Aug 24, 2023
Reiterated: Buy
Price Target: $9 → $5
Current: $3.18
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $0.925
Upside: n/a
Mar 23, 2023
Reiterated: Buy
Price Target: $8 → $4
Current: $4.43
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.6675
Upside: n/a
Jun 29, 2021
Reiterated: Buy
Price Target: $8
Current: $5.11
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.28
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.2918
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $43.36
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $4.69
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $0.971
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $16.27
Upside: n/a
Nov 21, 2012
Reiterated: Hold
Price Target: $46
Current: $89.50
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $44.11
Upside: n/a